OFIX U.S.: Nasdaq

    Orthofix Medical Inc.

    Set a price target alert
    After Hours
    Last Updated: Dec 8, 2023 4:28 p.m. EST Delayed quote

    $ 11.76

    0.00 0.00%
    After Hours Volume: 5.84K
    Close Chg Chg %
    $11.76 0.39 3.43%
    Advanced Charting
    Volume: 755.12K 65 Day Avg: 810.82K
    93% vs Avg
    11.21 Day Range 11.89
    9.58 52 Week Range 23.19

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    OFIX Overview

    Key Data

    • Open $11.37
    • Day Range 11.21 - 11.89
    • 52 Week Range 9.58 - 23.19
    • Market Cap $432.26M
    • Shares Outstanding 36.76M
    • Public Float 35.46M
    • Beta 0.94
    • Rev. per Employee $612.14K
    • P/E Ratio N/A
    • EPS -$3.90
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest 3.34M 11/15/23
    • % of Float Shorted 9.41%
    • Average Volume 810.82K


    5 Day
    • 5.76%
    1 Month
    • 17.60%
    3 Month
    • -35.98%
    • -42.72%
    1 Year
    • -42.18%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 5 Full Ratings

    Recent News

    Orthofix Taps LimaCorporate Chief for CEO

    Read full story

    Orthofix’s stock has worst day in nearly 30 years after 3 top executives are fired for ‘offensive conduct’

    Orthofix Medical Shares Drop About 16% After Board Ousts Top Executives

    Orthofix Medical’s stock tumbles 11.3% premarket after CEO, CFO and CLO terminated for cause

    SeaSpine stock soars after Orthofix merger deal at a near 38% premium

    Orthofix Medical upgraded to buy from hold at Stifel Nicolaus

    Medical device maker Orthofix warns that Q3 revenue will rise only in low-single digits as COVID delays procedures

    Orthofix Medical Inc. said Wednesday it expects third-quarter revenue growth to come in at a low single-digit increase over the year-earlier period, hurt by the high volume of elective procedures that have been deferred o...

    Orthofix Medical started at hold with $39 stock price target at Stifel Nicolaus

    Read full story

    Small- and microcap stocks get another look as the S&P 500 Index stalls

    Orthofix started at buy with $49 stock price target at SunTrust RH

    SEC fines Orthofix International $14 million for accounting failures, foreign bribery

    The Securities and Exchange Commission said on Wednesday it would fine Orthofix International , a Texas-based medical device company, $14 million to settle charges that it improperly booked revenue in certain instances and...

    Orthofix shares slide 2% in morning trade

    Orthofix to restate results due accounting errors

    Orthofix International NV said Tuesday it would restate its financial statements going back to 2011 after finding a series of accounting errors. The medical-device company found improper accounting of uncollectable patient...

    Orthofix delays second-quarter earnings

    Orthofix International NV postponed the release of its second-quarter results, as the medical-device company said it needs more time to review matters related to its sales and income totals in prior periods.

    NuVasive shares plunge as customers defect

    NuVasive Inc. (NUVA) lost a third of its market value Thursday after the maker of spinal products reduced its third-quarter revenue guidance because of customers and sales representatives defecting to smaller, lower-priced...

    Orthofix to pay $34 mln to settle DOJ probe

    Orthofix International N.V. (OFIX) has agreed to pay $34.2 million to settle False Claims Act allegations related to the medical-device company's sale of bone growth stimulator devices, the Department of Justice said.

    Orthofix to sell sports-medicine unit for $157.5M

    Orthofix International N.V. (OFIX) agreed to sell its sports medicine business Breg Inc. to private-equity firm Water Street Healthcare Partners for $157.5 million in cash in an effort to focus on its spine and orthopedic ...

    Biomet joint sales suffer from economic slowdown

    (Updates throughout with details on results, analyst comments.) --Replacement joint sales remain soft, similar to prior fiscal quarter --Biomet CEO cites volume and pricing pressure on industry, and says company isn't grow...

    Brown-Forman, Acadia, ADC, InterMune, more

    SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trading in Tuesday's session are Brown-Forman Corp., Chico's FAS Inc., and ADC Telecommunications.

    NRG Energy, NTL, Telewest, TiVo

    A look at companies whose shares are expected to se active trade in Monday's session.

    Alaska Air, Orthofix Medical And Other Big Stocks Moving Lower In Monday's Pre-Market Session

    on Benzinga.com

    Orthofix Medical: Hold Rating Affirmed Amid Leadership Changes and Integration Challenges

    on TipRanks.com

    Orthofix (OFIX) Gets a Hold from BTIG

    on TipRanks.com

    Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View Cut

    on Zacks.com

    Does Orthofix (OFIX) Have the Potential to Rally 78.73% as Wall Street Analysts Expect?

    on Zacks.com

    Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Orthofix (OFIX) and Amicus (FOLD)

    on TipRanks.com

    Orthofix Medical: Q3 Earnings Insights

    on Benzinga.com

    Paragon 28, Inc. (FNA) Surges 12.1%: Is This an Indication of Further Gains?

    on Zacks.com

    Hologic (HOLX) Earnings Expected to Grow: Should You Buy?

    on Zacks.com

    Orthofix (OFIX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    on Zacks.com

    Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023

    on Benzinga.com

    Orthofix (OFIX) Secures FDA 510k Clearance for OsteoCove Graft

    on Zacks.com

    Orthofix (OFIX) Soars 6.4%: Is Further Upside Left in the Stock?

    on Zacks.com

    Orthofix (OFIX) Unveils Gemini System, Advances in Trauma Wing

    on Zacks.com

    Director James Hinrichs Acquires 7,500 Shares of Orthofix Medical Inc

    Director James Hinrichs Acquires 7,500 Shares of Orthofix Medical Inc

    on GuruFocus.com

    Orthofix Medical Director Trades $101K In Company Stock

    on Benzinga.com

    Why Shares of Orthofix Medical Are Plummeting on Tuesday

    on Motley Fool

    JMP Securities Sticks to Their Hold Rating for Orthofix (OFIX)

    on TipRanks.com

    Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    on Benzinga.com

    12 Health Care Stocks Moving In Tuesday's Intraday Session

    on Benzinga.com

    Orthofix Medical Inc.

    Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.